US$ Million by Region/Country: 2020-2027
Table 2: Optocouplers Global Retrospective Market Scenario in
US$ Million by Region/Country: 2012-2019
Table 3: Optocouplers Market Share Shift across Key Geographies
Worldwide: 2012 VS 2020 VS 2027
Table 4: 4 Pin Optocoupler (Product Type) World Market by
Region/Country in US$ Million: 2020 to 2027
Table 5: 4 Pin Optocoupler (Product Type) Historic Market
Analysis by Region/Country in US$ Million: 2012 to 2019
Table 6: 4 Pin Optocoupler (Product Type) Market Share
Breakdown of Worldwide Sales by Region/Country: 2012 VS 2020 VS
2027
Markets Worldwide in US$ Million: 2020 to 2027
Table 8: 6 Pin Optocoupler (Product Type) Historic Market
Perspective by Region/Country in US$ Million: 2012 to 2019
Table 9: 6 Pin Optocoupler (Product Type) Market Sales
January 15, 2021
Both ESG investing and energy have been prevailing trends getting a lot of investor interest to start the new year. ETF issuer VanEck is seeing interest in some more places forward-thinking investors may want to consider.
® Agribusiness ETF (MOO): seeks to replicate as closely as possible, before fees and expenses, the price and yield performance of the MVIS
® Global Agribusiness Index (MVMOOTR), which is intended to track the overall performance of companies involved in: agri-chemicals, animal health and fertilizers, seeds and traits, from farm/irrigation equipment and farm machinery, aquaculture and fishing, livestock, cultivation and plantations (including grain, oil palms, sugar cane, tobacco leafs, grapevines, etc.), and trading of agricultural products. MOO gives investors:
Global Smart Pills Industry
New York, Dec. 30, 2020 (GLOBE NEWSWIRE) Reportlinker.com announces the release of the report Global Smart Pills Industry - https://www.reportlinker.com/p05960086/?utm source=GNW
2 Million by 2027, growing at a CAGR of 11.4% over the analysis period 2020-2027. Esophagus, one of the segments analyzed in the report, is projected to record a 12% CAGR and reach US$152.5 Million by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Small Intestine segment is readjusted to a revised 12.4% CAGR for the next 7-year period.